nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

06.07.2016 | Original Paper

The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study

verfasst von: Alessandro Rossi, Silvana Galderisi, Paola Rocca, Alessandro Bertolino, Armida Mucci, Paola Rucci, Dino Gibertoni, Eugenio Aguglia, Mario Amore, Ileana Andriola, Antonello Bellomo, Massimo Biondi, Gaetano Callista, Anna Comparelli, Liliana Dell’Osso, Massimo Di Giannantonio, Andrea Fagiolini, Carlo Marchesi, Palmiero Monteleone, Cristiana Montemagni, Cinzia Niolu, Giuseppe Piegari, Federica Pinna, Rita Roncone, Paolo Stratta, Elena Tenconi, Antonio Vita, Patrizia Zeppegno, Mario Maj, Italian Network for Research on Psychoses

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

The relationships of personal resources with symptom severity and psychosocial functioning have never been tested systematically in a large sample of people with schizophrenia. We applied structural equation models to a sample of 921 patients with schizophrenia collected in a nationwide Italian study, with the aim to identify, among a large set of personal resources, those that may have an association with symptom severity or psychosocial functioning. Several relevant demographic and clinical variables were considered concurrently. Poor service engagement and poor recovery style, as well as older age and younger age at onset, were related to greater symptom severity and poorer social functioning. Higher resilience and higher education were related to better social functioning only. Poor problem-focused coping and internalized stigma, as well as male gender and depression, were related to symptom severity only. The explored variables showed distinctive and partially independent associations with symptom severity and psychosocial functioning. A deeper understanding of these relationships may inform treatment decisions.

Brissos S, Balanzá-Martinez V, Dias VV, Carita AI, Figueira ML (2011) Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community? Eur Arch Psychiatry Clin Neurosci 261(7):509–517CrossRefPubMed

Schaub D, Brüne M, Jaspen E, Pajonk FG, Bierhoff HW, Juckel G (2011) The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci 261(2):85–93CrossRefPubMed

Gorwood P, Burns T, Juckel G, Rossi A, San L, Hargarter L et al (2013) Psychiatrists’ perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa. Ann Gen Psychiatry 12:8CrossRefPubMedPubMedCentral

Burns T, Patrick D (2007) Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand 116:403–418CrossRefPubMed

Nasrallah H, Morosini P, Gagnon DD (2008) Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res 161:213–224CrossRefPubMed

Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H et al (2008) Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia. Schizophr Res 104:287–293CrossRefPubMed

Oorschot M, Lataster T, Thewissen V, Lardinois M, van Os J, Delespaul PAEG et al (2012) Symptomatic remission in psychosis and real-life functioning. Br J Psychiatry 201:215–220CrossRefPubMed

Brissos S, Dias VV, Balanzá-Martinez V, Carita AI, Figueira ML (2011) Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr Res 129:133–136CrossRefPubMed

Leifker FR, Bowie CR, Harvey PD (2009) Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res 115:82–87CrossRefPubMed

10.

Tait L, Birchwood M, Trower P (2002) A new scale (SES) to measure engagement with community mental health services. J Ment Health 11:191–198CrossRefPubMed

11.

Tait L, Birchwood M, Trower P (2004) Adapting to the challenge of psychosis: personal resilience and the use of sealing-over (avoidant) coping strategies. Br J Psychiatry 185:410–415CrossRefPubMed

12.

Rudnick A, Martins J (2009) Coping and schizophrenia: a re-analysis. Arch Psychiatr Nurs 23:11–15CrossRefPubMed

13.

Livingston JD, Boyd JE (2010) Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med 71:2150–2161CrossRefPubMed

14.

Nugent WR, Thomas JW (1993) Validation of a clinical measure of self-esteem. Res Soc Work Pract 3:191–207CrossRef

15.

McGlashan TH, Levy ST, Carpenter WT (1975) Integration and sealing over. Clinically distinct recovery styles from schizophrenia. Arch Gen Psychiatry 32:1269–1272CrossRefPubMed

16.

McGlashan TH (1987) Recovery style from mental illness and long-term outcome. J Nerv Ment Dis 175:681–685CrossRefPubMed

17.

Drayton M, Birchwood M, Trower P (1998) Early attachment experience and recovery from psychosis. Br J Clin Psychol 37:269–284CrossRefPubMed

18.

Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY et al (2013) The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry 47:762–771CrossRefPubMed

19.

Zauszniewski JA, Bekhet AK, Suresky MJ (2010) Resilience in family members of persons with serious mental illness. Nurs Clin North Am 45:613–626CrossRefPubMed

20.

Torgalsbøen A-K (2012) Sustaining full recovery in schizophrenia after 15 years: does resilience matter? Clin Schizophr Relat Psychoses 5:193–200CrossRefPubMed

21.

Roe D, Yanos PT, Lysaker PH (2006) Coping with psychosis: an integrative developmental framework. J Nerv Ment Dis 194:917–924CrossRefPubMedPubMedCentral

22.

Lysaker PH, Roe D, Yanos PT (2007) Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull 33:192–199CrossRefPubMed

23.

Mashiach-Eizenberg M, Hasson-Ohayon I, Yanos PT, Lysaker PH, Roe D (2013) Internalized stigma and quality of life among persons with severe mental illness: the mediating roles of self-esteem and hope. Psychiatry Res 208:15–20CrossRefPubMedPubMedCentral

24.

Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P et al (2014) The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry 13:275–287CrossRefPubMedPubMedCentral

25.

Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276CrossRefPubMed

26.

Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162:441–449CrossRefPubMed

27.

Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323–329PubMed

28.

Patrick DL, Burns T, Morosini P, Rothman M, Gagnon DD, Wild D et al (2009) Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia. Curr Med Res Opin 25:325–338CrossRefPubMed

29.

Friborg O, Hjemdal O, Martinussen M, Rosenvinge JH (2009) Empirical support for resilience as more than the counterpart and absence of vulnerability and symptoms of mental disorder. J Individ Differ 30:138–151CrossRef

30.

Friborg O, Barlaug D, Martinussen M, Rosenvinge JH, Hjemdal O (2005) Resilience in relation to personality and intelligence. Int J Methods Psychiatr Res 14:29–42CrossRefPubMed

31.

Ritsher JB, Otilingam PG, Grajales M (2003) Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res 121:31–49CrossRefPubMed

32.

Poloni N, Callegari C, Buzzi A, Aletti F, Baranzini F, Vecchi F et al (2010) The Italian version of ISOS and RSQ, two suitable scales for investigating recovery style from psychosis. Epidemiol Psichiatr Soc 19:352–359PubMed

33.

Magliano L, Fadden G, Madianos M, de Almeida JM, Held T, Guarneri M et al (1998) Burden on the families of patients with schizophrenia: results of the BIOMED I study. Soc Psychiatry Psychiatr Epidemiol 33:405–412CrossRefPubMed

34.

Carver CS, Scheier MF, Weintraub JK (1989) Assessing coping strategies: a theoretically based approach. J Personal Soc Psychol 56:267–283CrossRef

35.

Tuncay T, Musabak I, Gok DE, Kutlu M (2008) The relationship between anxiety, coping strategies and characteristics of patients with diabetes. Health Qual Life Outcomes 6:79CrossRefPubMedPubMedCentral

36.

Stratta P, Capanna C, Carmassi C, Patriarca S, Di Emidio G, Riccardi I et al (2014) The adolescent emotional coping after an earthquake: a risk factor for suicidal ideation. J Adolesc 37:605–611CrossRefPubMed

37.

Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl 163:39–44

38.

Wallwork RS, Fortgang R, Hashimoto R, Weinberger DR, Dickinson D (2012) Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res 137:246–250CrossRefPubMedPubMedCentral

39.

Rabinowitz J, Levine SZ, Garibaldi G, Bugarski-Kirola D, Berardo CG, Kapur S (2012) Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res 137:147–150CrossRefPubMed

40.

Llorca P-M, Blanc O, Samalin L, Bosia M, Cavallaro R (2012) Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling. Eur Psychiatry 27:396–400CrossRefPubMed

41.

Bowie CR, Depp C, McGrath JA, Wolyniec P, Mausbach BT, Thornquist MH et al (2010) Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry 167:1116–1124CrossRefPubMedPubMedCentral

42.

Iosifescu DV (2012) The relation between mood, cognition and psychosocial functioning in psychiatric disorders. Eur Neuropsychopharmacol 22(Suppl 3):S499–S504CrossRefPubMed

43.

Karow A, Moritz S, Lambert M, Schöttle D, Naber D (2012) Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry 27:401–405CrossRefPubMed

44.

Karow A, Wittmann L, Schöttle D, Schäfer I, Lambert M (2014) The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci 16:185–195PubMedPubMedCentral

45.

Gerlinger G, Hauser M, De Hert M, Lacluyse K, Wampers M, Correll CU (2013) Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions. World Psychiatry 12:155–164CrossRefPubMedPubMedCentral

46.

Boyd JE, Adler EP, Otilingam PG, Peters T (2014) Internalized Stigma of Mental Illness (ISMI) Scale : a multinational review. Compr Psychiatry 55:221–231CrossRefPubMed

47.

Lysaker PH, Davis LW, Warman DM, Strasburger A, Beattie N (2007) Stigma, social function and symptoms in schizophrenia and schizoaffective disorder: associations across 6 months. Psychiatry Res 149:89–95CrossRefPubMed

48.

van Zelst C, van Nierop M, Oorschot M, Myin-Germeys I, van Os J, Delespaul P (2014) Stereotype awareness, self-esteem and psychopathology in people with psychosis. PLoS ONE 9:e88586CrossRefPubMedPubMedCentral

49.

Phillips LJ, Francey SM, Edwards J, McMurray N (2009) Strategies used by psychotic individuals to cope with life stress and symptoms of illness: a systematic review. Anxiety Stress Coping 22:371–410CrossRefPubMed

50.

Aldwin CM, Revenson TA (1987) Does coping help? A reexamination of the relation between coping and mental health. J Personal Soc Psychol 53:337–348CrossRef

51.

Ritsner M, Ben-Avi I, Ponizovsky A, Timinsky I, Bistrov E, Modai I (2003) Quality of life and coping with schizophrenia symptoms. Qual Life Res 12:1–9CrossRefPubMed

52.

Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T et al (2006) Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 67:1690–1697CrossRefPubMed

53.

Carpiniello B, Pinna F, Tusconi M, Zaccheddu E, Fatteri F (2012) Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study. Schizophr Res Treat 2012:576369

54.

Karow A, Naber D, Lambert M, Moritz S (2012) Remission as perceived by people with schizophrenia, family members and psychiatrists. Eur Psychiatry 27:426–431CrossRefPubMed

55.

Suttajit S, Arunpongpaisal S, Srisurapanont M, Thavichachart N, Kongsakon R, Chantakarn S et al (2015) Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains? Neuropsychiatr Dis Treat 11:2471–2477CrossRefPubMedPubMedCentral

56.

McGurk SR, Meltzer HY (2000) The role of cognition in vocational functioning in schizophrenia. Schizophr Res 45:175–184CrossRefPubMed

57.

Mueser KT, Salyers MP, Mueser PR (2001) A prospective analysis of work in schizophrenia. Schizophr Bull 27:281–296CrossRefPubMed

58.

Macpherson R, Jerrom B, Hughes A (1996) Relationship between insight, educational background and cognition in schizophrenia. Br J Psychiatry 168:718–722CrossRefPubMed

59.

Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP et al (2006) Randomized controlled trial of the effect on quality of life of second-vs first-generation antipsychotic drugs in schizophrenia. Arch Gen Psychiatry 63(10):1079–1087CrossRefPubMed

60.

Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31–41CrossRefPubMed

Titel: The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study
verfasst von: Alessandro Rossi
Silvana Galderisi
Paola Rocca
Alessandro Bertolino
Armida Mucci
Paola Rucci
Dino Gibertoni
Eugenio Aguglia
Mario Amore
Ileana Andriola
Antonello Bellomo
Massimo Biondi
Gaetano Callista
Anna Comparelli
Liliana Dell’Osso
Massimo Di Giannantonio
Andrea Fagiolini
Carlo Marchesi
Palmiero Monteleone
Cristiana Montemagni
Cinzia Niolu
Giuseppe Piegari
Federica Pinna
Rita Roncone
Paolo Stratta
Elena Tenconi
Antonio Vita
Patrizia Zeppegno
Mario Maj
Italian Network for Research on Psychoses
Publikationsdatum: 06.07.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 4/2017
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-016-0710-9

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Psychopathological and demographic characteristics of hallucinating patients with schizophrenia and schizoaffective disorder: an analysis based on AMDP data

A trans-diagnostic approach to psychosis, psychiatric medication nomenclature and stigma

Gender does matter in clinical research

The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns

Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie